CALLIDITAS THERAPEUTICS-ADR (CALT)

US13124Q1067 - ADR

19.5006  +0.05 (+0.26%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.21B802.88M229.35M874.00K184.83M
Minority Interest Expense
N/A0.009.24M3.02MN/A
Cost Of Goods
60.46M15.20MN/AN/AN/A
Gross Profit
1.15B787.68MN/AN/AN/A
Operating Expenses
1.52B1.20B753.95M383.08M212.71M
Research and Development
502.22M413.10M357.49M241.37M149.83M
Selling, General, and Administrative Expenses
1.06B763.40M390.23M141.72M62.88M
Operating Income
-373.06M-414.81M-524.61M-382.20M-27.88M
Interest Income/Expense
-83.96M10.27M13.38M-50.63M-1.86M
Other Income/Expense
N/A-4.87M-2.15M-3.32M-2.70M
Non Recurring Items
N/AN/AN/AN/A-61.00K
Income Before Taxes
-457.02M-409.42M-513.37M-436.15M-32.50M
Income Tax
9.17M2.85M-3.84M360.00K77.00K
Net Income
-466.19M-412.27M-500.29M-433.49M-32.58M
EBITDA
N/AN/AN/AN/A-26.06M
 
Per Share Data
EPS Diluted Total Ops
-17.37-15.55-19.69-19.32-1.76
Non GAAP EPS
-17.36N/AN/AN/AN/A
 
Statistics
Gross Profit Margin
94.99%98.11%N/AN/AN/A
Profit Margin
-38.63%-51.35%-218.14%-49598.86%-17.63%
Operating Profit Margin
-30.91%-51.67%-228.74%-43730.21%-15.08%

All data in SEK

Charts